Pharmaceutical industry is an industry concerned with the development, production and marketing of curative drugs, which are licensed for use. This industry is easy to operate because with the use of technical knowhow, one can understand the metabolism associated with diseases and pathogens, and with the use of chemistry and biology, manipulation can be done to these pathways. This is easier to carry out since earlier drug discoveries have been carried out at institutions of higher learning like the universities and research firms and therefore, advancing from the traditional usage of the herbal medicine (Brooks, Weatherston & Wilkinson 2011, p.17). Like the other products, drugs should also be developed to ensure that they are sustained for a reliable medication. This is usually done to ensure effective formulation, dosing and the safety measures. The research done in these fields require clinical trials after conducting an extensive study. Capital is very essential in conducting product development.This is due to the high cost involved in the maintenance of quality controls, marketing, distribution and the manufacturing process(Hamilton and Webster, 2012, p.12). In addition, collaborative contracts between research firms and other large pharmaceutical companies such as Global Ventures Limited can be formed to discover the possibility of new drugs. Drug companies are managed like other companies because they deal in the production of commercial goods to ensure the companies’ growth and development. They industry is very risky as compared to the others. Drug invention and innovation is quite expensive. Of all compounds used by human beings, only a small percentage are finally approved in most states by the government appointed medical institutions and boards, who should endorse the usage of new drugs before they can enter the market. There are estimated costs that take into account the cost of the most forgone of investing resources, which is usually done many years before the realization of revenues (Dicken 2007, p. 9). They should consider the time value of money. Competition amongst most worldwide companies has led to production of drugs with chemically, which uses the same system of action as an existing and accepted chemical component. Most competitors usually use the me-too drugs and they avail them at the market since their development is less expensive and less risky as compared to those with the original mechanism of action. The company will have to look to research team for viable studies that will make the pharmaceutical industrial commodities attract the customers. They should be sponsored and remunerated for example, by supporting their symposium and consultation costs. Journal articles and lecture scripts presented by these academic researchers may actually not be true. This means that these researchers who have tried to reveal the ethical issues with medical trials or who tried to publish these journals with harmful effects on newly introduced drugs or devising cheaper differentiated drugs should be threatened with law suits by the company(Brooks, Weatherston & Wilkinson 2011, p. 39). Pharmaceutical industries in the United Kingdom